✦ LIBER ✦

CN3 Cost Effectiveness of Liposomal Doxorubicin Versus Paclitaxel for the Treatment of Aids-Ks

✍ Scribed by Raimundo, K.; Asche, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN24 PEGYLATED LIPOSOMAL DOXORUBICIN IN

✍ CJ Gibbons; K Yong; G Roberts 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PSS20 COST-EFFECTIVENESS OF TOBRADEX VER

✍ A Rahman; C Waycaster; D Smith 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The Cost-Effectiveness of Nonsurgical Ve

✍ Jay Pomerance; David Zurakowski; Ilene Fine 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 277 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PIN16 COST-EFFECTIVENESS ANALYSIS OF MIC

✍ A Odeyemi; WM Hart; II Odeyemi; P Musingarimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-effectiveness of natalizumab versus

✍ O’Day, Ken; Meyer, Kellie; Miller, Ross M.; Agarwal, Sonalee; Franklin, Meg 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 373 KB